J. Goldman & Co’s IVERIC bio, Inc. Common Stock ISEE Stock Holding History

J. Goldman & Co’s Portfolio ISEE Stock Details ISEE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-135,000	Closed	-$5.31M	–	532
2023 Q2	$5.31M	Buy	+135,000	New	+$4.77M	0.19%	129

J. Goldman & Co's ISEE Position: Q3 2023 in Review

J. Goldman & Co sold out of IVERIC bio, Inc. Common Stock (ISEE) in Q3 2023, closing a stake of 11,136 shares — an estimated $438K sold.

J. Goldman & Co first reported a position in ISEE in Q3 2021 and held it in 8 quarters. The position peaked at $6.54M in Q4 2022. 0 funds tracked by Wall St. Rank hold ISEE as of Q3 2023.

J. Goldman & Co reported no remaining IVERIC bio, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
J. Goldman & Co sold 11,136 IVERIC bio, Inc. Common Stock shares in Q3 2023, an estimated $438K.
J. Goldman & Co first reported a position in IVERIC bio, Inc. Common Stock in Q3 2021 and held it in 8 quarters.
J. Goldman & Co's IVERIC bio, Inc. Common Stock position peaked at $6.54M in Q4 2022.
0 funds tracked by Wall St. Rank held IVERIC bio, Inc. Common Stock as of Q3 2023.

Based on J. Goldman & Co's 13F filing for Q3 2023, filed 14 Nov 2023.